Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)

Background: The use of nutraceutical products and functional foods in the cardiovascular and metabolic field is rising in several countries. Preparation and implementation of guidelines are pivotal for translating research-derived knowledge and evidence-based medicine to the clinical practice. Based...

Descripción completa

Detalles Bibliográficos
Autores principales: Casula, Manuela, Catapano, Alberico Luigi, Magni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839347/
https://www.ncbi.nlm.nih.gov/pubmed/35276964
http://dx.doi.org/10.3390/nu14030606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839347/
https://www.ncbi.nlm.nih.gov/pubmed/35276964
http://dx.doi.org/10.3390/nu14030606

Ejemplares similares